Personalized treatment of neuropathic pain: Where are we now?

D Bouhassira, N Attal - European Journal of Pain, 2023 - Wiley Online Library
Background The treatment of neuropathic pain remains a major unmet need that the
development of personalized and refined treatment strategies may contribute to address …

Improving neuropathic pain treatment–by rigorous stratification from bench to bedside

N Soliman, D Kersebaum, T Lawn… - Journal of …, 2023 - Wiley Online Library
Chronic pain is a constantly recurring and persistent illness, presenting a formidable
healthcare challenge for patients and physicians alike. Current first‐line analgesics offer …

Profiling migraine patients according to clinical and psychophysical characteristics: a cluster analysis approach

S Di Antonio, L Arendt-Nielsen, M Ponzano… - Pain …, 2023 - academic.oup.com
Aim This study aims to profile migraine patients according clinical and psychophysical
characteristics. Method In this observational study, two cohorts of migraine patients …

[HTML][HTML] Central sensitization in cancer survivors and its clinical implications: state of the art

T Nishigami, M Manfuku, A Lahousse - Journal of Clinical Medicine, 2023 - mdpi.com
Although the prevalence of cancer pain is 47% after treatment, cancer pain is often
underestimated, and many patients are undertreated. The complexity of cancer pain …

Altered somatosensory functioning and mechanism‐based classification in breast cancer patients with persistent pain

V Haenen, L Dams, M Meeus… - The Anatomical …, 2024 - Wiley Online Library
Pain is one of the most frequent and persistent side effects of breast cancer treatment.
Besides pain, breast cancer survivors (BCS) are prone to experience a myriad of other signs …

[HTML][HTML] Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these …

S Somersan-Karakaya, KC Turner, L Cortes-Burgos… - Neurobiology of Pain, 2023 - Elsevier
The artemin-GFRα3 signaling pathway has been implicated in various painful conditions
including migraine, cold allodynia, hyperalgesia, inflammatory bone pain, and mouse knees …

[HTML][HTML] Detection of altered pain facilitatory and inhibitory mechanisms in patients with knee osteoarthritis by using a simple bedside tool kit (QuantiPain)

M Izumi, Y Hayashi, R Saito, S Oda, KK Petersen… - Pain …, 2022 - journals.lww.com
Purpose: Altered pain facilitatory and inhibitory mechanisms have been recognized as an
important manifestation in patients with chronic pain, and quantitative sensory testing (QST) …

[HTML][HTML] Reflections from the OARSI 2022 clinical trials symposium: The pain of OA—Deconstruction of pain and patient-reported outcome measures for the benefit of …

MA Karsdal, J Tambiah, D Felson, C Ladel… - Osteoarthritis and …, 2023 - Elsevier
Objective Osteoarthritis (OA) drug development is hampered by a number of challenges.
One of the main challenges is the apparent discordance between pain and structure, which …

[HTML][HTML] Cervical musculoskeletal impairments and pain sensitivity in migraine patients

S Di Antonio, L Arendt-Nielsen, M Castaldo - Musculoskeletal Science and …, 2023 - Elsevier
Introduction Currently, examination of migraine patients relies on a clinical interview
investigating symptoms characteristics. Despite this, to help identify distinct migraine …

Subgrouping of facilitatory or inhibitory conditioned pain modulation responses in patients with chronic knee pain. Explorative analysis from a multicentre trial

JB Larsen, P Madeleine, LB Sørensen… - … Journal of Pain, 2024 - Wiley Online Library
Background Facilitatory and inhibitory conditioned pain modulation (CPM) responses are
observed in healthy volunteers and chronic pain patients, but the clinical implications for …